A s an initiator and cofounder of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use, I am pleased to see that this famous “ICH” initiative is still alive and well. I had the privilege of participating directly in this unique process until 2000, as a representative of the European Commission and later as the fi r st director of the European Medicines Agency (EMA).